Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial

Kidney Disease ◽

Autosomal Dominant ◽

Controlled Trial ◽

Secondary Analysis ◽

Polycystic Kidney ◽

Randomized Controlled ◽

Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2016.07.023 ◽

2016 ◽

Vol 68 (6) ◽

pp. 882-891 ◽

Cited By ~ 22

Author(s):

Osama W. Amro ◽

Jessica K. Paulus ◽

Farzad Noubary ◽

Ronald D. Perrone

Keyword(s):

Kidney Disease ◽

Water Intake ◽

Autosomal Dominant ◽

Controlled Trial ◽

Polycystic Kidney ◽

Randomized Controlled ◽

Autosomal Dominant Polycystic Kidney ◽

Pilot Randomized Controlled Trial

Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-015-0692-3 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 6

Author(s):

Markus Riegersperger ◽

Harald Herkner ◽

Gere Sunder-Plassmann

Keyword(s):

Kidney Disease ◽

Study Protocol ◽

Autosomal Dominant ◽

Controlled Trial ◽

Polycystic Kidney ◽

Randomized Controlled ◽

Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2018.12.037 ◽

2019 ◽

Vol 74 (2) ◽

pp. 213-223 ◽

Cited By ~ 2

Author(s):

Kristen L. Nowak ◽

Berenice Gitomer ◽

Heather Farmer-Bailey ◽

Wei Wang ◽

Mikaela Malaczewski ◽

...

Keyword(s):

Kidney Disease ◽

Vascular Function ◽

Autosomal Dominant ◽

Controlled Trial ◽

Polycystic Kidney ◽

Randomized Controlled ◽

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial

European Journal of Pediatrics ◽

10.1007/s00431-019-03384-x ◽

2019 ◽

Vol 178 (7) ◽

pp. 1013-1021 ◽

Cited By ~ 3

Author(s):

Franz Schaefer ◽

Djalila Mekahli ◽

Francesco Emma ◽

Rodney D. Gilbert ◽

Detlef Bockenhauer ◽

...

Keyword(s):

Kidney Disease ◽

Children And Adolescents ◽

Autosomal Dominant ◽

Controlled Trial ◽

Polycystic Kidney ◽

Double Blind ◽

Double Blind Placebo ◽

Low-Dose Rapamycin (Sirolimus) Effects in Autosomal Dominant Polycystic Kidney Disease: An Open-Label Randomized Controlled Pilot Study

Clinical Journal of the American Society of Nephrology ◽

10.2215/cjn.02650313 ◽

2014 ◽

Vol 9 (5) ◽

pp. 881-888 ◽

Cited By ~ 34

Author(s):

William E. Braun ◽

Jesse D. Schold ◽

Brian R. Stephany ◽

Rita A. Spirko ◽

Brian R. Herts

Keyword(s):

Pilot Study ◽

Kidney Disease ◽

Low Dose ◽

Autosomal Dominant ◽

Polycystic Kidney ◽

Open Label ◽

Randomized Controlled ◽

Faculty Opinions recommendation of The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740754366.793588580 ◽

2021 ◽

Author(s):

Albert Ong ◽

Zhiguo Mao

Keyword(s):

Kidney Disease ◽

Autosomal Dominant ◽

Controlled Trial ◽

Polycystic Kidney ◽

Correction:Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

BMJ Open ◽

10.1136/bmjopen-2017-018794corr1 ◽

2018 ◽

Vol 8 (8) ◽

pp. e018794corr1 ◽

Cited By ~ 1

Keyword(s):

Kidney Disease ◽

Water Intake ◽

Kidney Failure ◽

Autosomal Dominant ◽

Controlled Trial ◽

Efficacy And Safety ◽

Polycystic Kidney ◽

Sirolimus for Treatment of Autosomal-Dominant Polycystic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials

Transplantation Proceedings ◽

10.1016/j.transproceed.2013.10.040 ◽

2014 ◽

Vol 46 (1) ◽

pp. 66-74 ◽

Cited By ~ 15

Author(s):

Y.-M. Liu ◽

Y.Q. Shao ◽

Q. He

Keyword(s):

Kidney Disease ◽

Randomized Controlled Trials ◽

Autosomal Dominant ◽

Meta Analysis ◽

Controlled Trials ◽

Polycystic Kidney ◽

Randomized Controlled ◽

Effect of Sirolimus on Native Total Kidney Volume After Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Pilot Study

Transplantation Proceedings ◽

10.1016/j.transproceed.2018.02.060 ◽

2018 ◽

Vol 50 (5) ◽

pp. 1243-1248 ◽

Cited By ~ 1

Author(s):

S. Davis ◽

J. Gralla ◽

L. Chan ◽

A. Wiseman ◽

C.L. Edelstein

Keyword(s):

Pilot Study ◽

Kidney Disease ◽

Autosomal Dominant ◽

Kidney Volume ◽

Polycystic Kidney ◽

Total Kidney Volume ◽

Randomized Controlled ◽

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial

QJM ◽

10.1093/qjmed/hcz326 ◽

2020 ◽

Vol 113 (4) ◽

pp. 306-306 ◽

Cited By ~ 1

Author(s):

R El-Damanawi ◽

M Lee ◽

T Harris ◽

L B Cowley ◽

S Bond ◽

...

Keyword(s):

Kidney Disease ◽

Water Intake ◽

Autosomal Dominant ◽

High Water ◽

Feasibility Trial ◽

Polycystic Kidney ◽

Randomized Controlled ◽

Ad Libitum ◽